ABSTRACT Respiratory muscle function was assessed in six patients with the Lambert-Eaton myasthenic syndrome. Five had histologically proved small cell carcinoma of the lung; the sixth later developed metastases from an unknown primary site. Two patients had ventilatory failure, one without respiratory symptoms; another, who had emphysema, had dyspnoea and orthopnoea. The remaining three patients had no respiratory symptoms. Four patients had limb muscle weakness as judged by the maximal voluntary contraction of the quadriceps muscle (range for all subjects 32-100% predicted). Transdiaphragmatic pressure (Pdi) was measured during a maximal unoccluded sniff (Pdi: sniff), a maximal sustained inspiratory effort against a closed airway (Pdi: Pimax), and phrenic nerve stimulation (Pdi: twitch). Mild to moderate diaphragmatic weakness was present in all six patients in proportion to the degree of leg weakness (Pdi: sniff 30-64% predicted; r = 0-6; Pdi:Pimax 6-69% predicted, r = 0-8); this was associated with very low or absent Pdi:twitch during phrenic nerve stimulation. Four patients had weakness of the expiratory muscles. Improvement in muscle strength was documented in two patients after tumour chemotherapy and specific treatment with 3,4-diaminopyridine and prednisolone; one patient was still alive five years from first diagnosis. It is concluded that the respiratory muscles may be implicated in this condition more often than has previously been recognised. As the lack ofmobility may cause respiratory symptoms to be minimised, the presence of respiratory muscle weakness may remain undiagnosed unless formal measurement of respiratory muscle function is made.
Introduction
The Lambert-Eaton myasthenic syndrome is an autoimmune disorder of neuromuscular transmission,' in which IgG antibodies to presynaptic calcium channels lead to their down regulation,2' thereby reducing calcium dependent, nerve impulse evoked acetylcholine release. About 60% of patients with the Lambert-Eaton myasthenic syndrome have an underlying small cell carcinoma of the lungs. 5 The syndrome gives rise to a predominantly proximal muscle weakness, which early in the disease improves transiently after sustained contraction (post-tetanic potentiation). It also causes depression or absence of tendon reflexes, autonomic disorders (dry mouth, constipation, impotence) and, as in other disorders of neuromuscular transmission, abnormal sensitivity to muscle relaxant drugs. 6 Ventilatory failure has been reported in patients with the Lambert-Eaton myasthenic syndrome after muscle relaxant drugs,6 and there are a few isolated case reports of spontaneous ventilatory failure in this syndrome.5" Lesser degrees of respiratory muscle weakness have not been documented. We therefore studied six patients with the syndrome to investigate the extent to which respiratory muscles are affected.
Patients
We studied six unselected patients, five male and one female (table 1) with clinical and electrophysiological findings typical of the Lambert-Eaton myasthenic syndrome (table 2). The diagnosis was initially made at the National Hospital for Nervous Diseases, London, and the patients were subsequently referred to the Brompton Hospital for investigation of underlying malignancy. Five patients were consecutive referrals to the Brompton Hospital with newly diagnosed Lambert-Eaton myasthenic syndrome, and the sixth (patient 5) was under review when the study was started. Cerebellar symptoms were prominent in two patients (Nos 1 and 6), who had no evidence of intracerebral metastases on computed tomograms. 913 914 Laroche, Mier, Spiro, Newsom-Davis, Moxham, Green One patient (No 2) had severe autonomic manifestations. Five patients had histologically proved small cell carcinoma of the lung. In the sixth patient (No 2) no evidence of malignancy had been found at the time of study. One patient (No 1) had not noticed any respiratory symptoms but was found to be in ventilatory failure at the time of study, arterial oxygen (Pao2) and carbon dioxide (Paco2) tensions being 6-9 and 6 5 kPa. Patient 4 presented with ventilatory failure (Pao2 with 4 1/min oxygen 7-4 kPa, Pco2 7 3 kPa), with progressively severe dyspnoea and a vital capacity of only 1-2 1. Respiratory muscle strength was not formally assessed until he had received 10 days' treatment with prednisolone, 3,4-diaminopyridine (a drug that increases transmitter release from motor nerve terminals8), antitumour chemotherapy, intensive physiotherapy, and drugs for coexisting inappropriate antidiuretic hormone secretion. By this time his vital capacity had improved to 19 litres and his Pao2 (while he was breathing oxygen 6 I/min) to 10-1 kPa and Pco2 to 5 9 kPa. Arterial blood gas tensions were not measured in the other three patients.
Patient 5 was studied three years after diagnosis. His carcinoma ofthe lung had responded to chemotherapy and the limb muscle weakness had partially responded to continuous treatment with prednisolone and 3,4-diaminopyridine. His severe dyspnoea and orthopnoea had been attributed to emphysema, and coexisting respiratory muscle weakness had not been 
Discussion
It has been suggested that respiratory muscle weakness is rare in the Lambert-Eaton myasthenic syndromeless common than in, for example, myasthenia gravis.7 This has not been investigated, however, with specific tests of respiratory muscle function. One report described a single patient with the Lambert-Eaton myasthenic syndrome in whom very low mouth pressures suggested severe global respiratory muscle weakness, and electrophysiological studies of the phrenic nerve suggested that the diaphragm was affected.'8 This is consistent with our findings in a further six patients, in whom respiratory muscle strength was found to correlate with the strength of the quadriceps muscle.
The incidence of mild to moderate respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome has probably been underestimated in the past, because of the relative lack of respiratory symptoms in patients with reduced exercise tolerance due to limb weakness or cerebellar ataxia. In addition, vital capacity may be preserved until quite severe respiratory muscle weakness is present.'9 The true extent of respiratory muscle weakness in patients with the Lambert-Eaton myasthenic syndrome can be assessed only by formal measurement of maximum respiratory pressures. Detection and quantification of respiratory muscle weakness is important because Respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome weakness may give rise to respiratory infection or progress to frank respiratory failure. If the possibility is considered early, it may allow preventive measures to be taken before such events occur.
In some of our patients there was evidence of a progressive increase in respiratory pressures during successive maximal voluntary respiratory efforts. This may reflect the post-tetanic potentiation seen in the Lambert-Eaton myasthenic syndrome, but as substantial improvement is seen in many normal subjects during successive attempts at these manoeuvres it is not clear to what extent this observation was attributable to the syndrome. Extra care must be taken with these patients to ensure that they make sufficient efforts to achieve maximum pressures.
The reduced amplitude of the diaphragm mass action potential and reduction in Pdi:twitch on electrical stimulation of the phrenic nerves confirm that the diaphragm was specifically affected by the Lambert-Eaton myasthenic syndrome in all six patients, and reflects the findings reported for other peripheral muscles in this syndrome.5 Phrenic nerve stimulation appeared to be even more sensitive than measurement of maximum respiratory pressures in detecting respiratory muscle weakness as shown by the reduction in Pdi:twitch and diaphragm mass action potential amplitude in patient 6 despite only marginal reduction in maximum Pdi generated during maximum inspiratory efforts. This may reflect the underlying abnormality of neuromuscular transmission in this disorder, which characteristically improves transiently during a maximum voluntary contraction.5
The classical diagnostic findings in the peripheral muscles of patients with the Lambert-Eaton myasthenic syndrome are a decline in amplitude ofthe mass action potential when the frequency of stimulation is increased to 3 Hz, with a progressive increase in amplitude when the frequency of stimulation is increased above 10 Hz.' We were unable to detect any fall in diaphragm mass action potential amplitude with stimulation of the phrenic nerves at 3 Hz in our patients. Quantitative measurement of mass action potential amplitude in the diaphragm is, however, less reliable than in peripheral muscles.2' We did not attempt to increase the frequency of stimulation to show the characteristic increase in action potential amplitude at a high frequency of stimulation as this is not well tolerated by patients.
The slight prolongation of phrenic nerve conduction time in two ofour patients was not associated with a corresponding reduction in conduction velocity in other muscles. Conduction velocity is usually normal in muscles other than the diaphragm in patients with the Lambert-Eaton myasthenic syndrome, prolongation occurring in only two of 50 patients with the disorder in one study.5 The abnormal finding in two of our patients may reflect the technical difficulty of measuring phrenic nerve conduction time when mass action potential amplitude is greatly reduced.
One of the two patients with ventilatory failure (patient 1) showed only a moderate degree of respiratory muscle weakness, and did not appear to have significant coexisting lung or airways disease. Cerebellar dysfunction may have resulted in abnormal respiratory muscle activation,22 causing some primary alveolar hypoventilation.
Identification of respiratory muscle weakness is important in patients with the Lambert-Eaton myasthenic syndrome as results in two of our patients suggest that it may respond to specific treatment. The outlook for these patients remains poor because of the underlying carcinoma. One of our patients, however, remains well controlled with 3,4-diaminopyridine and prednisolone five years after the initial presentation.
In conclusion, our results show that the respiratory muscles are usually implicated in this condition, at least when it is associated with cancer. They emphasise the need to assess respiratory muscle strength specifically in patients with appreciable limb weakness due to the Lambert-Eaton myasthenic syndrome.
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